EPO offers strong protection against brain edema, which is partially mediated by diminishing the mitogen‐activated protein kinase pathway (MAPK) activity‐dependent overabundance of aquaporin4 (AQP4) in ischemia and reperfusion‐like injury (Tang et al., 2013). This evidence concerns the gene EPO and ischemia.